Immunotherapy: The Future of Prostate Cancer is Here, with Charles Drake
On September 30, 2014, Charles G. Drake, M.D., Ph.D., an associate professor of oncology at Johns Hopkins University, discussed current immunotherapy treatment options for patients with prostate cancer, and how close we are to making these treatments available to more patients.
This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, was generously supported by Dendreon.
These webinars are offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Видео Immunotherapy: The Future of Prostate Cancer is Here, with Charles Drake канала Cancer Research Institute
This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, was generously supported by Dendreon.
These webinars are offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Видео Immunotherapy: The Future of Prostate Cancer is Here, with Charles Drake канала Cancer Research Institute
Показать
Комментарии отсутствуют
Информация о видео
2 октября 2014 г. 1:13:16
00:48:16
Другие видео канала
![2019 CRI Immunotherapy Patient Summit in Baltimore with Chawnte'](https://i.ytimg.com/vi/9e4rTh2RG8U/default.jpg)
![2019 CRI Immunotherapy Patient Summit in Baltimore with Suzanne L. Topalian, M.D.](https://i.ytimg.com/vi/mKu9NyMCILQ/default.jpg)
![Seek Out the Best Care You Can: Oswald’s Cancer Immunotherapy Story](https://i.ytimg.com/vi/zHD5ebr3JBc/default.jpg)
![Tamron Hall Wraps Up Day 1 of the 2021 CRI Virtual Immunotherapy Patient Summit](https://i.ytimg.com/vi/oHTxK0Kb-Gk/default.jpg)
![Patient Perspective: Karen Koehler, Leukemia Survivor - NYC Immunotherapy Patient Summit 2018](https://i.ytimg.com/vi/sFatS-6L9mU/default.jpg)
![Todo sobre los ensayos clínicos](https://i.ytimg.com/vi/3PJ6arkWG1E/default.jpg)
![Dr. Raymond Shim Commits to #CrushCancer](https://i.ytimg.com/vi/UglLBJzceOA/default.jpg)
![2019 CRI Immunotherapy Patient Summit in Baltimore with Ron](https://i.ytimg.com/vi/XNOQ7sQdnoE/default.jpg)
![Skin Cancer/Melanoma Breakout: Learning from a decade of success](https://i.ytimg.com/vi/m32THb_fsM4/default.jpg)
![Demystifying Cancer Immunotherapy Clinical Trials – NYC Immunotherapy Patient Summit 2017](https://i.ytimg.com/vi/h7auE1YwwgE/default.jpg)
![A Future #Immune2Cancer: CRI Scientific Advisory Council Associate Director Dr. Kunle Odunsi](https://i.ytimg.com/vi/RNmMMn_JCpo/default.jpg)
![Highlights from the 2014 Annual Awards Dinner](https://i.ytimg.com/vi/OTr_hwdRbGg/default.jpg)
![Interview with CRI Lloyd J. Old STAR Peter E. Fecci, M.D., Ph.D.](https://i.ytimg.com/vi/HNlyL233aB8/default.jpg)
![Bringing Hope to Ovarian Cancer Patients](https://i.ytimg.com/vi/QiGnNb54NS0/default.jpg)
![LaToya's Breast Cancer Survival Story](https://i.ytimg.com/vi/YCQ8kwtR2iQ/default.jpg)
![2018 CRI Immunotherapy Patient Summit-KC](https://i.ytimg.com/vi/FkJpLWwsz_8/default.jpg)
![Immunotherapy Means Life: Karen’s Breast Cancer Story](https://i.ytimg.com/vi/EY74RlEVoiI/default.jpg)
![Creating a Future #Immune2Cancer: Dr. Adilia Hormigo on Overcoming Glioblastoma Treatment Barriers](https://i.ytimg.com/vi/uNy7QC0Nf7o/default.jpg)
![Advancing the Next Wave in Cancer Treatment](https://i.ytimg.com/vi/an3cPezKuYw/default.jpg)
![Changing Life After Colorectal Cancer: Ron’s Immunotherapy Story](https://i.ytimg.com/vi/4x231WxG3XM/default.jpg)
![A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research](https://i.ytimg.com/vi/x_opgLTE_jY/default.jpg)